STOCK TITAN

[8-K] INTERNATIONAL BUSINESS MACHINES CORP Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

IBM filed an 8-K under Item 7.01 (Regulation FD), furnishing materials for its third-quarter 2025 earnings presentation to investors on October 22, 2025. The company provided prepared remarks from the Chairman and CEO Arvind Krishna and CFO Jim Kavanaugh as Exhibit 99.1, and the presentation slides as Exhibit 99.2.

Non-GAAP reconciliations for measures discussed in the presentation are included in Exhibit 99.2. The information in Item 7.01 and Exhibits 99.1 and 99.2 is being furnished, not filed, under the Securities Exchange Act of 1934.

IBM ha depositato un 8-K ai sensi della voce 7.01 (Regulation FD), fornendo materiali per la sua presentazione sugli utili del terzo trimestre 2025 agli investitori il 22 ottobre 2025. L'azienda ha fornito osservazioni preparate del presidente e CEO Arvind Krishna e del CFO Jim Kavanaugh come Esibizione 99.1, e le diapositives della presentazione come Esibizione 99.2.

Riconciliazioni non-GAAP per le misure discusse nella presentazione sono incluse in Esibizione 99.2. Le informazioni in Item 7.01 e negli Esibizioni 99.1 e 99.2 vengono fornite, non depositate, ai sensi del Securities Exchange Act del 1934.

IBM presentó un 8-K bajo el ítem 7.01 (Regulation FD), proporcionando materiales para su presentación de resultados del tercer trimestre 2025 a los inversores el 22 de octubre de 2025. La empresa proporcionó observaciones preparadas del presidente y CEO Arvind Krishna y del CFO Jim Kavanaugh como Anexo 99.1, y las diapositivas de la presentación como Anexo 99.2.

R esto No-GAAP para las medidas discutidas en la presentación están incluidas en el Anexo 99.2. La información en el ítem 7.01 y los Anexos 99.1 y 99.2 se están proporcionando, no presentando, conforme a la Securities Exchange Act de 1934.

IBM은 7.01항(규정 FD)에 따라 8-K를 제출했고, 2025년 3분기 실적 발표 자료를 2025년 10월 22일 투자자들에게 제공했습니다. 회사는 회장 겸 CEO 아빈드 크리슈나와 CFO 짐 캐번엇의 준비 발언Exhibit 99.1로, 그리고 발표 슬라이드Exhibit 99.2로 제공했습니다.

발표에서 다룬 지표에 대한 Non-GAAP 조정은 Exhibit 99.2에 포함되어 있습니다. Item 7.01 및 Exhibits 99.1 및 99.2의 정보는 1934년 증권거래법에 따라 제출된 것이 아니라 제공된 것입니다.

IBM a déposé un 8-K en vertu de l’Article 7.01 (Regulation FD), mettant à disposition des investisseurs les documents pour sa présentation sur les résultats du troisième trimestre 2025, le 22 octobre 2025. La société a fourni des prises de parole préparées du président et PDG Arvind Krishna et du directeur financier Jim Kavanaugh en tant que Annexe 99.1, et les diapositives de la présentation en tant que Annexe 99.2.

Rapprochements Non-GAAP pour les mesures discutées dans la présentation sont inclus dans l’Annexe 99.2. Les informations relatées à l’Item 7.01 et les Annexes 99.1 et 99.2 sont fournies, et non déposées, en vertu de la Securities Exchange Act de 1934.

IBM hat eine 8-K gemäß Item 7.01 (Regulation FD) eingereicht, um Materialien für die Gewinnpräsentation im dritten Quartal 2025 den Investoren am 22. Oktober 2025 bereitzustellen. Das Unternehmen stellte vorbereitete Bemerkungen des Vorsitzenden und CEO Arvind Krishna und des CFO Jim Kavanaugh als Anlage 99.1 sowie die Präsentationsfolien als Anlage 99.2 zur Verfügung.

Non-GAAP-Zusammenfassungen der in der Präsentation diskutierten Kennzahlen sind in Anlage 99.2 enthalten. Die Informationen in Item 7.01 und den Anlagen 99.1 und 99.2 werden bereitgestellt, nicht eingereicht gemäß dem Securities Exchange Act von 1934.

قدمت IBM استمارة 8-K وفقاً للبند 7.01 (Regulation FD)، وتزوّد المستثمرين بمواد عرض أرباح الربع الثالث 2025 في 22 أكتوبر 2025. قدّمت الشركة كلمات مُعدة من رئيس مجلس الإدارة والرئيس التنفيذي أرڤيند كريشنا والمدير المالي جيم كافاناف كـ المرفق 99.1، و شرائح العرض كـ المرفق 99.2.

التسويات غير GAAP للقياسات التي نوقشت في العرض متضمنة في المرفق 99.2. المعلومات في البند 7.01 وفي المرفقين 99.1 و99.2 يتم توفيرها، وليست مقدمة، وفقاً لقانون الأوراق المالية لعام 1934.

IBM 提交了基于第7.01条(Regulation FD)的8-K,向投资者提供了其2025年第三季度收益发布的材料,时间为2025年10月22日。公司提供了来自董事长兼首席执行官阿文德·克里希纳和首席财务官吉姆·卡瓦诺夫的准备致辞,作为附件 99.1,以及作为附件 99.2演示文稿幻灯片

非GAAP对账用于本次演示中讨论的指标,包含在附件 99.2中。根据1934年证券交易法,关于第7.01条信息及附件99.1、99.2的信息是提供(furnished),而非提交(filed)

Positive
  • None.
Negative
  • None.

IBM ha depositato un 8-K ai sensi della voce 7.01 (Regulation FD), fornendo materiali per la sua presentazione sugli utili del terzo trimestre 2025 agli investitori il 22 ottobre 2025. L'azienda ha fornito osservazioni preparate del presidente e CEO Arvind Krishna e del CFO Jim Kavanaugh come Esibizione 99.1, e le diapositives della presentazione come Esibizione 99.2.

Riconciliazioni non-GAAP per le misure discusse nella presentazione sono incluse in Esibizione 99.2. Le informazioni in Item 7.01 e negli Esibizioni 99.1 e 99.2 vengono fornite, non depositate, ai sensi del Securities Exchange Act del 1934.

IBM presentó un 8-K bajo el ítem 7.01 (Regulation FD), proporcionando materiales para su presentación de resultados del tercer trimestre 2025 a los inversores el 22 de octubre de 2025. La empresa proporcionó observaciones preparadas del presidente y CEO Arvind Krishna y del CFO Jim Kavanaugh como Anexo 99.1, y las diapositivas de la presentación como Anexo 99.2.

R esto No-GAAP para las medidas discutidas en la presentación están incluidas en el Anexo 99.2. La información en el ítem 7.01 y los Anexos 99.1 y 99.2 se están proporcionando, no presentando, conforme a la Securities Exchange Act de 1934.

IBM은 7.01항(규정 FD)에 따라 8-K를 제출했고, 2025년 3분기 실적 발표 자료를 2025년 10월 22일 투자자들에게 제공했습니다. 회사는 회장 겸 CEO 아빈드 크리슈나와 CFO 짐 캐번엇의 준비 발언Exhibit 99.1로, 그리고 발표 슬라이드Exhibit 99.2로 제공했습니다.

발표에서 다룬 지표에 대한 Non-GAAP 조정은 Exhibit 99.2에 포함되어 있습니다. Item 7.01 및 Exhibits 99.1 및 99.2의 정보는 1934년 증권거래법에 따라 제출된 것이 아니라 제공된 것입니다.

IBM a déposé un 8-K en vertu de l’Article 7.01 (Regulation FD), mettant à disposition des investisseurs les documents pour sa présentation sur les résultats du troisième trimestre 2025, le 22 octobre 2025. La société a fourni des prises de parole préparées du président et PDG Arvind Krishna et du directeur financier Jim Kavanaugh en tant que Annexe 99.1, et les diapositives de la présentation en tant que Annexe 99.2.

Rapprochements Non-GAAP pour les mesures discutées dans la présentation sont inclus dans l’Annexe 99.2. Les informations relatées à l’Item 7.01 et les Annexes 99.1 et 99.2 sont fournies, et non déposées, en vertu de la Securities Exchange Act de 1934.

IBM hat eine 8-K gemäß Item 7.01 (Regulation FD) eingereicht, um Materialien für die Gewinnpräsentation im dritten Quartal 2025 den Investoren am 22. Oktober 2025 bereitzustellen. Das Unternehmen stellte vorbereitete Bemerkungen des Vorsitzenden und CEO Arvind Krishna und des CFO Jim Kavanaugh als Anlage 99.1 sowie die Präsentationsfolien als Anlage 99.2 zur Verfügung.

Non-GAAP-Zusammenfassungen der in der Präsentation diskutierten Kennzahlen sind in Anlage 99.2 enthalten. Die Informationen in Item 7.01 und den Anlagen 99.1 und 99.2 werden bereitgestellt, nicht eingereicht gemäß dem Securities Exchange Act von 1934.

0000051143falseCHX00000511432025-10-222025-10-220000051143us-gaap:CommonStockMemberexch:XNYS2025-10-222025-10-220000051143us-gaap:CommonStockMemberexch:XCHI2025-10-222025-10-220000051143ibm:Notes2.875PercentDue2025Memberexch:XNYS2025-10-222025-10-220000051143ibm:Notes0.300PercentDue2026Memberexch:XNYS2025-10-222025-10-220000051143ibm:Notes1.250PercentDue2027Memberexch:XNYS2025-10-222025-10-220000051143ibm:A3375NotesDue2027Memberexch:XNYS2025-10-222025-10-220000051143ibm:Notes0.300PercentDue2028Memberexch:XNYS2025-10-222025-10-220000051143ibm:Notes1.750PercentDue2028Memberexch:XNYS2025-10-222025-10-220000051143ibm:Notes1.500PercentDue2029Memberexch:XNYS2025-10-222025-10-220000051143ibm:Notes0.875PercentDue2030Memberexch:XNYS2025-10-222025-10-220000051143ibm:A2.900NotesDue2030Memberexch:XNYS2025-10-222025-10-220000051143ibm:Notes1.750PercentDue2031Memberexch:XNYS2025-10-222025-10-220000051143ibm:A3625NotesDue2031Memberexch:XNYS2025-10-222025-10-220000051143ibm:Notes0.650PercentDue2032Memberexch:XNYS2025-10-222025-10-220000051143ibm:A3.150NotesDue2033Memberexch:XNYS2025-10-222025-10-220000051143ibm:Notes1.250PercentDue2034Memberexch:XNYS2025-10-222025-10-220000051143ibm:A3750NotesDue2035Memberexch:XNYS2025-10-222025-10-220000051143ibm:A3.450NotesDue2037Memberexch:XNYS2025-10-222025-10-220000051143ibm:A4875NotesDue2038Memberexch:XNYS2025-10-222025-10-220000051143ibm:Notes1.200PercentDue2040Memberexch:XNYS2025-10-222025-10-220000051143ibm:A4000NotesDue2043Memberexch:XNYS2025-10-222025-10-220000051143ibm:A3.800NotesDue2045Memberexch:XNYS2025-10-222025-10-220000051143ibm:Debentures7.00PercentDue2025Memberexch:XNYS2025-10-222025-10-220000051143ibm:Debentures6.22PercentDue2027Memberexch:XNYS2025-10-222025-10-220000051143ibm:Debentures6.50PercentDue2028Memberexch:XNYS2025-10-222025-10-220000051143ibm:Debentures5.875PercentDue2032Memberexch:XNYS2025-10-222025-10-220000051143ibm:Debentures7.00PercentDue2045Memberexch:XNYS2025-10-222025-10-220000051143ibm:Debentures7.125PercentDue2096Memberexch:XNYS2025-10-222025-10-22

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report: October 22, 2025
(Date of earliest event reported)
INTERNATIONAL BUSINESS MACHINES CORPORATION
(Exact name of registrant as specified in its charter)
New York 1-236013-0871985
(State of Incorporation)(Commission File Number)(IRS employer Identification No.)
One New Orchard Road
Armonk, New York
10504
(Address of principal executive offices)(Zip Code)
914-499-1900
(Registrant’s telephone number)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Capital stock, par value $.20 per shareIBMNew York Stock Exchange
NYSE Texas
2.875% Notes due 2025IBM 25ANew York Stock Exchange
0.300% Notes due 2026IBM 26BNew York Stock Exchange
1.250% Notes due 2027IBM 27BNew York Stock Exchange
3.375% Notes due 2027IBM 27FNew York Stock Exchange
0.300% Notes due 2028IBM 28BNew York Stock Exchange
1.750% Notes due 2028IBM 28ANew York Stock Exchange
1.500% Notes due 2029IBM 29New York Stock Exchange
0.875% Notes due 2030IBM 30ANew York Stock Exchange
2.900% Notes due 2030IBM 30CNew York Stock Exchange
1.750% Notes due 2031IBM 31New York Stock Exchange
3.625% Notes due 2031IBM 31BNew York Stock Exchange
0.650% Notes due 2032IBM 32ANew York Stock Exchange
3.150% Notes due 2033IBM 33ANew York Stock Exchange
1.250% Notes due 2034IBM 34New York Stock Exchange
3.750% Notes due 2035IBM 35New York Stock Exchange
3.450% Notes due 2037IBM 37New York Stock Exchange
4.875% Notes due 2038IBM 38New York Stock Exchange
1.200% Notes due 2040IBM 40New York Stock Exchange
4.000% Notes due 2043IBM 43New York Stock Exchange
3.800% Notes due 2045IBM 45ANew York Stock Exchange
7.00% Debentures due 2025IBM 25New York Stock Exchange
6.22% Debentures due 2027IBM 27New York Stock Exchange
6.50% Debentures due 2028IBM 28New York Stock Exchange
5.875% Debentures due 2032IBM 32DNew York Stock Exchange
7.00% Debentures due 2045IBM 45New York Stock Exchange
7.125% Debentures due 2096IBM 96New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 7.01. Regulation FD Disclosure.
Exhibit 99.1 of this Form 8-K contains the prepared remarks for IBM's Chairman, President and Chief Executive Officer Arvind Krishna and Chief Financial Officer Jim Kavanaugh's third-quarter 2025 earnings presentation to investors on October 22, 2025.
The slides for IBM's Chairman, President and Chief Executive Officer Arvind Krishna and Chief Financial Officer Jim Kavanaugh's third-quarter 2025 earnings presentation on October 22, 2025, are Exhibit 99.2 to this Form 8-K.
Reconciliations of non-GAAP financial measures discussed in the earnings presentation to the most directly comparable financial measures calculated and presented in accordance with GAAP are included in Exhibit 99.2 to this Form 8-K.
The information in this Item 7.01, including the corresponding Exhibits 99.1 and 99.2, is being furnished with the Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934.
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits
The following exhibits are being furnished as part of this report:
Exhibit No.Description of Exhibit
99.1
Prepared Remarks of Earnings Presentation on October 22, 2025
99.2
Earnings Presentation of the Registrant, dated October 22, 2025

The following exhibit is being filed as part of this report:
Exhibit No.Description of Exhibit
104Cover Page Interactive Data File (embedded within the Inline XBRL Document)

IBM’s web site (www.ibm.com) contains a significant amount of information about IBM, including financial and other information for investors (www.ibm.com/investor/). IBM encourages investors to visit its various web sites from time to time, as information is updated and new information is posted.
2


SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Date: October 23, 2025
By:/s/ Nicolás A. Fehring
Nicolás A. Fehring
Vice President and Controller
3

FAQ

What did IBM (IBM) disclose in this 8-K?

IBM furnished materials for its Q3 2025 earnings presentation, including prepared remarks (Exhibit 99.1) and slides (Exhibit 99.2).

Are the non-GAAP reconciliations available for IBM's presentation?

Yes. Reconciliations to the most comparable GAAP measures are included in Exhibit 99.2.

Is the information in IBM's 8-K filed or furnished?

The Item 7.01 information and Exhibits 99.1 and 99.2 are furnished, not filed.

When was IBM’s Q3 2025 investor presentation delivered?

The presentation to investors took place on October 22, 2025.

Who delivered IBM’s Q3 2025 prepared remarks?

Prepared remarks were from Arvind Krishna (Chairman, President and CEO) and Jim Kavanaugh (CFO).

Where can investors find IBM’s investor materials online?

IBM’s website provides investor information at www.ibm.com/investor/.
International Business Machines Corp

NYSE:IBM

IBM Rankings

IBM Latest News

IBM Latest SEC Filings

IBM Stock Data

262.74B
930.28M
0.12%
65.15%
1.53%
Information Technology Services
Computer & Office Equipment
Link
United States
ARMONK